Langendorff Symposium

Dear colleagues, Dear patients,

Continuing the fruitful research cooperation in the tradition of Hanns Langendorff, we are honored to invite you to the 8th Langendorff Symposiumin Freiburg!

The past years in lung cancer research have yielded new therapeutic options. Due to a very strong interdisciplinary collaboration and research, the Medical Center – University of Freiburg is one of the leading centers in treating lung cancer in Germany. Recently, we have successfully completed two prospective trials sponsored by German Cancer Aid:

1) STRIPE (PI: A.-L. Grosu) evaluated the role of SBRT in inoperable lung lesions.
2) PET-Plan (PI: U. Nestle), a multi-center randomized trial, compared FDG-PET and CT for target volume delineation in patients treated with definitive radiochemotherapy for locally advanced lung cancer. We would be honored to discuss these interesting results with you.

The symposium will be a platform for presenting new interdisciplinary ,translational aspects in the evolving field of lung cancer. Focal points will include diagnosis, functional and biological imaging, immunology, targeted therapies, surgery, and radiation therapy.

Join a multidisciplinary reunion of specialists in an international contribution for improving clinical practice and providing optimal care for our patients!